ICON plc has signed an extension to its strategic agreement with Eli Lilly and Company to manage the company's clinical data management outside the US. This extension means that ICON will now also manage Lilly's needs in Japan in addition to those in Europe, Canada, Latin America, Australia and Asia, which was originally agreed in November 2008. Lilly also selected ICON to manage clinical trial site set up and monitoring in Europe for Lilly managed studies in June 2009.

ICON plc reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009. The company reported net revenues for the quarter were $220.3 million, representing a 2.3% decrease over net revenues of $225.5 million for the comparative quarter last year. On a constant organic dollar basis revenues were similar to prior year. Income from operations was increased by 12% to $30.4 million, compared to $27.1 million for the same quarter last year. Net income was $24 million, compared with $21.4 million last year an increase of 12%. EPS of 40 cents per share on a diluted basis represented an increase of 14% over 35 cents per share last year. For the quarter ended September 30, 2009, cash provided by operating activities was $70 million and capital expenditure was $9.6 million. For the nine months, the company reported net revenues were $660.2 million, representing a 2.3% increase over the same period last year. For the period income from operations, before one time net charges, was $86.6 million, compared to $73.0 million last year representing an operating margin increase to 13.1% from 11.3%. Net income before one time net charges was $67.7 million or $1.13 per share, compared with $57.1 million or 93 cents per share last year representing an increase in EPS of 22%. The company revised earnings guidance for the full year of 2009. The company expects EPS Guidance for 2009 raised to $1.48-$1.52, excluding previously booked one time net charge.

ICON plc expected to Report Fiscal Year 2009 Results on February 15, 2010. This event was calculated by Capital IQ (Created on September 1, 2009).